{"id":"NCT01292057","sponsor":"Medical University of South Carolina","briefTitle":"Aripiprazole Effects on Alcohol Drinking and Craving","officialTitle":"Impulsivity and Drinking/Craving: Effect of a Dopamine Stabilizer Medication","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-02","primaryCompletion":"2015-12","completion":"2015-12","firstPosted":"2011-02-09","resultsPosted":"2017-07-07","lastUpdate":"2017-08-08"},"enrollment":99,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Alcohol Dependence"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aripiprazole","type":"ACTIVE_COMPARATOR"},{"label":"Sugar pill","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether aripiprazole (marketed dopamine stabilizer) is effective in reducing of alcohol craving and drinking compared to placebo depending on participant's baseline level of impulsivity.","primaryOutcome":{"measure":"Total Number of Drinks Per Day During Natural (Usual Environment) Conditions","timeFrame":"6-day observation period","effectByArm":[{"arm":"Aripiprazole","deltaMin":5.8,"sd":0.4},{"arm":"Sugar Pill","deltaMin":6.4,"sd":0.4}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["28493623"],"seeAlso":["http://www.nlm.nih.gov/medlineplus/","http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp","http://druginfo.nlm.nih.gov/drugportal/drugportal.jsp","http://clinicaltrials.gov/ct2/info/fdalinks"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":47},"commonTop":["Daytime sleepiness","Trouble sleeping","Low energy","Trouble concentrating","Irritability"]}}